Malavi Madireddi
About Malavi Madireddi
Malavi Madireddi is the Scientific Director of Immunoscience at Bristol-Myers Squibb, with over 20 years of experience in scientific strategy and drug discovery.
Title at Bristol-Myers Squibb
Malavi Madireddi currently serves as the Scientific Director, Immunoscience, Innovative Medicines Development at Bristol-Myers Squibb in New Jersey, United States. In this role, Malavi leverages extensive experience in scientific strategy and discovery research to drive innovative immunoscience initiatives, working on both internal and alliance-based programs.
Previous Roles and Experience
Before becoming the Scientific Director, Immunoscience, Innovative Medicines Development, Malavi Madireddi held several key roles at Bristol-Myers Squibb, including Senior Principal Scientist, Fibrosis - NASH, DKD, and Principal Scientist, Metabolic Diseases - Diabetes. Earlier in the career, Malavi also worked as a Senior Research Investigator II focused on metabolic diseases such as obesity, and as Research Investigator I concentrated on oxidative stress and aging-related diseases.
Consultancy and Leadership Roles
Malavi Madireddi broadened expertise beyond Bristol-Myers Squibb by working as a Consultant at Gerson Lehrman Group in New York, New York, and as Senior Director of Clinical Trials Management at JDRF International. These roles allowed Malavi to apply scientific insights and strategic management skills to diverse challenges in clinical trials and consultancy.
Educational Background
Malavi Madireddi holds an MS from Andhra Pradesh Agricultural University, Hyderabad, India, and a PhD from Syracuse University. This strong academic foundation laid the groundwork for an accomplished career in scientific research and innovative medicines development.
Scientific Contributions and Specializations
In a distinguished career, Malavi Madireddi co-led the discovery of the Anti-myostatin adnectin (BMS-986089/ RG6206) for muscle-related diseases. With over 20 years of direct experience in drug discovery and early development, Malavi specializes in areas such as fibrosis, diabetes, obesity, oncology, and sarcopenia/cachexia. Expertise extends to endocrine growth factors, cytokines, oxidative stress, and translational medicine.